Acuitas Therapeutics, the Vancouver, BC-based biotech company co-founded by NMIN research leader Dr. Pieter Cullis, has been granted a Global Impact Award by Life Sciences British Columbia, in recognition of the company’s “extraordinary leadership and efforts they made in the development of COVID-19 vaccines.” Acuitas partnered with Pfizer and BioNTech… Read More »Acuitas Therapeutics wins Global Impact Award for LNPs in COVID vaccines

“There is no time like the present to try to achieve impossible dreams” The contributions of NMIN Research Leader Dr. Pieter Cullis toward enabling effective mRNA vaccines, most notably against COVID-19, continue to garner high-profile recognition. Most recently, Dr. Cullis was featured on CBC’s Quirks & Quarks; his role was… Read More »LNPs & mRNA vaccines: Dr. Pieter Cullis in Nature Reviews Materials

NMIN’s Scientific Director Dr. Christine Allen has named Dr. Warren Chan the new co-leader of NMIN’s Theme III: Diagnostics research team. “I’m delighted that Dr. Chan has agreed to take on this role,” comments Dr. Allen. “He is a world renowned expert in diagnostics and an excellent role model for… Read More »Dr. Warren Chan named co-leader of NMIN’s Diagnostics Theme

NMIN is collaborating with its partner organization NanoCanada to build a Canadian Nanomedicine Cluster that will offer a hub for collaboration and partnerships, provide a database of expertise and capabilities, and showcase Canada’s leadership on the global stage. As part of this collaboration, NMIN Executive Director Dr. Diana Royce has… Read More »NMIN supports NanoCanada’s Canadian Nanomedicine Cluster initiative

NMIN submitted its second Annual Progress Report to the NCE on 15 June 2021. The report compiled the network’s progress as of the end of 2020-21, accomplished despite the challenges associated with the COVID-19 pandemic. Among the achievements reported: NMIN has made 32 research investments, including 24 research projects, 2… Read More »NMIN’s Annual Progress Report compiles 2020-21 achievements